✦ LIBER ✦

6594 Phase II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients

✍ Scribed by Morizane, C.; Okusaka, T.; Ikeda, M.; Furuse, J.; Ohkawa, S.; Nakachi, K.; Suzuki, E.; Ueno, M.

Book ID: 122064364
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 46 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71315-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of gemcitabine as a fix

Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients

✍ Chigusa Morizane; Takuji Okusaka; Hideki Ueno; Shunsuke Kondo; Masafumi Ikeda; J 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 226 KB

3544 POSTER Phase I study of gemcitabine

3544 POSTER Phase I study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy in gemcitabine-refractory pancreatic cancer patients.

✍ C. Morizane; T. Okusaka; J. Furuse; H. Ishii; H. Ueno; M. Ikeda; T. Ogura; K. Na 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB

6595 POSTER Phase I Study of Gemcitabine

6595 POSTER Phase I Study of Gemcitabine as a Fixed Dose Rate Infusion and S-1 Combination Therapy (FGS) in Gemcitabine-refractory Biliary Tract Cancer (BTC) Patients

✍ Kojima, Y.; Ikeda, M.; Ueno, H.; Morizane, C.; Nakachi, K.; Mitsunaga, S.; Kondo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Phase II study of a fixed dose-rate infu

Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer

✍ J. Feliu; P. Borrega; A. León; L. López-Gómez; M. López; J. Castro; C. Belda-Ini 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 287 KB

A phase 1 study of fixed dose rate gemci

A phase 1 study of fixed dose rate gemcitabine and irinotecan in patients with advanced pancreatic and biliary cancer

✍ Weijing Sun; Maureen R. Hewitt; Marry R. Theobald; Diane Hershock; Daniel G. Hal 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND. The combination of a fixed dose rate (FDR) infusion of gemcitabine and irinotecan may have a synergistic effect in the treatment of patients with advanced and metastatic pancreatic and biliary cancer. The current study was conducted to determine the dose‐limiting toxicit

A multicenter phase II study of gemcitab

A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer

✍ Do-Youn Oh; Yongjun Cha; In-Sil Choi; So-Young Yoon; In Keun Choi; Jee Hyun Kim; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 352 KB